Education
About Us
Working with TipRanks
Follow Us
QuidelOrtho (QDEL)
NASDAQ:QDEL
QDEL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.77 - $49.45
Previous CloseN/A
Volume114.08K
Average Volume (3M)1.43M
Market Cap
$1.86B
Enterprise Value$2.38B
Total Cash (Recent Filing)$127.10M
Total Debt (Recent Filing)$557.10M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Jul 31, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.74
Shares Outstanding67,625,870
10 Day Avg. Volume1,070,654
30 Day Avg. Volume1,432,584
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)0.65
Price to Sales (P/S)0.00
P/FCF Ratio64.20
Enterprise Value/Market Cap1.28
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda-0.58
Forecast
1Y Price Target
$44.29Price Target Upside66.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
QuidelOrtho News
PremiumCompany Announcements
QuidelOrtho Stockholders Approve Equity Plan Changes
PremiumCompany Announcements
QuidelOrtho Earnings Call: Growth Amid Challenges
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe company announced additional cost savings initiatives, which are expected to enhance financial performance.
EarningsThe company's EBITDA margins have improved significantly, showing a 450 basis point increase year-over-year.
ValuationThe company's valuation has become more favorable, with EV/EBITDA now below its 3-year average.
Bears Say
Revenue ExpectationsThere is a decrease in first-quarter revenue expectations primarily driven by a reduction in COVID and flu revenue.
Tariff ExposureQuidelOrtho faces challenges due to tariff exposure, with a significant portion of revenue coming from China and being subject to U.S. tariffs.
UncertaintyEstimating the earnings impact from tariffs is extremely challenging, creating uncertainty around profitability estimates.
Ownership Overview
0.68% Insiders
38.64% Mutual Funds
1.67% Other Institutional Investors
27.90% Public Companies and Individual Investors
QDEL FAQ
What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest stock price was $23.77 and its highest was $49.45 in the past 12 months.
What is QuidelOrtho’s market cap?
QuidelOrtho’s market cap is $1.86B.
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s upcoming earnings report date is Jul 31, 2025 which is in 12 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on May 07, 2025. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.587 by $0.153.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Undervalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is <0.01.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 67,625,870 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of $0.74 in its last earnings report, beating expectations of $0.587. Following the earnings report the stock price went up 41.044%.
Which hedge fund is a major shareholder of QuidelOrtho?
Currently, no hedge funds are holding shares in QDEL
QuidelOrtho Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$44.29 (66.00% Upside)
$44.29 (66.00% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 18.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.3%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.44%
12-Months-Change
Fundamentals
Return on Equity
-10.59%
Trailing 12-Months
Asset Growth
-3.61%
Trailing 12-Months
Company Description
QuidelOrtho
QuidelOrtho Corporation (QDEL) is a prominent player in the healthcare sector, specializing in diagnostics and clinical testing solutions. The company manufactures and markets a wide array of diagnostic healthcare products, including rapid diagnostic tests, traditional laboratory tests, and clinical chemistry and immunoassay instruments. QuidelOrtho’s offerings cater to a variety of settings, such as hospitals, laboratories, and clinics, providing crucial support in disease detection and patient health management.
QDEL Company Deck
QDEL Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted solid revenue growth excluding COVID impacts, improved profitability metrics, and effective cost-saving measures. However, challenges such as declining total revenue, COVID-related declines, and tariff impacts were noted. Despite these challenges, the company is confident in its mitigation strategies and maintains its financial guidance.Read More>QDEL Stock 12 Month Forecast
Average Price Target
$44.29
▲(66.00%Upside)